1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global BiPAP Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global BiPAP Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
4.4.2. Market Volume/Unit Shipments Projections
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Key Industry Events
5.3. Top 3 Players Operating in the Market Space
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global BiPAP Devices Market Analysis and Forecast, by Indication
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Indication, 2017–2031
6.3.1. Chronic Obstructive Pulmonary Disease
6.3.2. Sleep Apnea
6.3.3. Asthma
6.3.4. Others
6.4. Market Attractiveness Analysis, by Indication
7. Global BiPAP Devices Market Analysis and Forecast, by Age Group
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Age Group, 2017–2031
7.3.1. Adult
7.3.2. Pediatric
7.4. Market Attractiveness Analysis, by Age Group
8. Global BiPAP Devices Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Sleep Facilities
8.3.3. Homecare
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global BiPAP Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America BiPAP Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Indication, 2017–2031
10.2.1. Chronic Obstructive Pulmonary Disease
10.2.2. Sleep Apnea
10.2.3. Asthma
10.2.4. Others
10.3. Market Value Forecast, by Age Group, 2017–2031
10.3.1. Adult
10.3.2. Pediatric
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Sleep Facilities
10.4.3. Homecare
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Indication
10.6.2. By Age Group
10.6.3. By End-user
10.6.4. By Country
11. Europe BiPAP Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Indication, 2017–2031
11.2.1. Chronic Obstructive Pulmonary Disease
11.2.2. Sleep Apnea
11.2.3. Asthma
11.2.4. Others
11.3. Market Value Forecast, by Age Group, 2017–2031
11.3.1. Adult
11.3.2. Pediatric
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Sleep Facilities
11.4.3. Homecare
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Indication
11.6.2. By Age Group
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific BiPAP Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Indication, 2017–2031
12.2.1. Chronic Obstructive Pulmonary Disease
12.2.2. Sleep Apnea
12.2.3. Asthma
12.2.4. Others
12.3. Market Value Forecast, by Age Group, 2017–2031
12.3.1. Adult
12.3.2. Pediatric
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Sleep Facilities
12.4.3. Homecare
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Indication
12.6.2. By Age Group
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America BiPAP Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Indication, 2017–2031
13.2.1. Chronic Obstructive Pulmonary Disease
13.2.2. Sleep Apnea
13.2.3. Asthma
13.2.4. Others
13.3. Market Value Forecast, by Age Group, 2017–2031
13.3.1. Adult
13.3.2. Pediatric
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Sleep Facilities
13.4.3. Homecare
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Indication
13.6.2. By Age Group
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa BiPAP Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Indication, 2017–2031
14.2.1. Chronic Obstructive Pulmonary Disease
14.2.2. Sleep Apnea
14.2.3. Asthma
14.2.4. Others
14.3. Market Value Forecast, by Age Group, 2017–2031
14.3.1. Adult
14.3.2. Pediatric
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Sleep Facilities
14.4.3. Homecare
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Indication
14.6.2. By Age Group
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Beijing Aeonmed Co., Ltd.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Indication Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. BMC Medical Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Indication Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Drive DeVilbiss Healthcare
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Indication Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Hebei Topson Medical Technology Co., Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Indication Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Koninklijke Philips N.V.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Indication Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.6. Löwenstein Medical Technology GmbH
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Indication Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.7. React Health
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Indication Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.8. ResMed Corp.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Indication Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.9. SEFAM
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Indication Portfolio
15.3.9.3. Financial Overview
15.3.10. Somnetics International, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Indication Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.11. Oventus Medical
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Indication Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
Table 01: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 02: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 03: Global BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global BiPAP Devices Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 07: North America BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 08: North America BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 11: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 12: Europe BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 15: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 16: Asia Pacific BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 19: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 20: Latin America BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Indication, 2017–2031
Table 23: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by Age Group, 2017–2031
Table 24: Middle East & Africa BiPAP Devices Market Value (US$ Mn) Forecast, by End-user, 2017–2031
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer